Cargando…
Safety profile of treatments administered in COVID 19 infection in pregnant women
SARS-CoV-2 infection has unexpectedly arrived in our society. In pregnant women, the situation has been similar to general population. Some drugs have been used empirically, and obstetricians have to consider whether the same treatments used in the general population were valid for pregnant women wi...
Autores principales: | Martínez-Sánchez, N., De la Calle Fernández-Miranda, M., Bartha, J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906532/ https://www.ncbi.nlm.nih.gov/pubmed/33654337 http://dx.doi.org/10.1016/j.gine.2021.01.004 |
Ejemplares similares
-
A reasoned approach towards administering COVID‐19 vaccines to pregnant women
por: Pramanick, Angsumita, et al.
Publicado: (2021) -
Awareness of resuscitation guidelines in pregnant women
por: Calle, S., et al.
Publicado: (2017) -
The Knowledge and Perceptions of Florida Pharmacists in Administering Inactivated Influenza Vaccines to Pregnant Women
por: Falope, Oluyemisi, et al.
Publicado: (2021) -
Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani, Imène, et al.
Publicado: (2013) -
Management of pregnant women infected with COVID-19
por: Luo, Yongwen, et al.
Publicado: (2020)